Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Melissa Campanelli"'
Autor:
Fulvio Massaro, Massimo Breccia, Robin Foà, Melissa Campanelli, Daniela Diverio, Daniela De Benedittis, Martina Canichella, Maria Lucia De Luca, Laura Cesini, Roberto Latagliata, Matteo Molica, Ida Carmosino, Marco Mancini, Sara Mohamed, Gioia Colafigli, Giuliana Alimena, Luisa Quattrocchi, Maria Giovanna Loglisci, Federico Vozella
Publikováno v:
European journal of haematology.
OBJECTIVES To evaluate differences in clinical results according to age among patients with chronic myeloid leukemia (CML). METHODS 207 consecutive CML patients treated with imatinib frontline were revised, dividing them in young adults (>20
Autor:
Roberta Murru, Alessandra Tedeschi, Alessandro Gozzetti, Anna Guarini, Robin Foà, Fortunato Morabito, Giovanni Del Poeta, Anna Maria Frustaci, Melissa Campanelli, Sara Raponi, Luca Laurenti, Piero Galieni, Gianluigi Reda, Idanna Innocenti, Maria D Caputo, Francesca Romana Mauro, Marina Motta, Massimo Gentile
Publikováno v:
American journal of hematology. 92(6)
We hereby report the clinical and biologic features of 33 of 4680 (0.7%) patients with chronic lymphocytic leukemia (CLL), managed at 10 Italian centers, who developed Hodgkin lymphoma (HL), a rare variant of Richter syndrome. The median age at CLL a
Autor:
Manlio Ferrarini, Annamaria Petrungaro, Massimo Gentile, Anna Guarini, Robin Foà, Giuseppina Uccello, Sara Raponi, Francesca Ronco, Antonino Neri, Francesca Romana Mauro, Iolanda Vincelli, Adriano Salaroli, Melissa Campanelli, Luigi Petrucci, Fortunato Morabito, Mauro Nanni
Publikováno v:
Leukemia research. 57
The prognostic effect of hypogammaglobulinemia (HGG), clinical and biologic characteristics on the infection risk and outcome has been retrospectively analyzed in 899 patients with stage A chronic lymphocytic leukemia (CLL). Low levels of IgG were re
Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients
Autor:
Sameer A. Parikh, Massimo Gentile, Manlio Ferrarini, Idanna Innocenti, Francesca Romana Mauro, Stefano Molica, Davide Rossi, Ernesto Vigna, Kari G. Chaffee, Robin Foà, Anna Grazia Recchia, Raffaella Pasquale, Antonino Neri, Giovanni Tripepi, Giuseppina Uccello, Giovanna Cutrona, Fortunato Morabito, Gianluca Gaidano, Melissa Campanelli, Luca Laurenti, Tait D. Shanafelt, Sabrina Bossio
To the editor: Recently, an international collaboration collected information from ∼3500 chronic lymphocytic leukemia (CLL) patients to develop a comprehensive tool for predicting overall survival (OS) (the international prognostic index for patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21b5078f8fe02b1a519b87f85d41c9d2
https://europepmc.org/articles/PMC5524531/
https://europepmc.org/articles/PMC5524531/
Autor:
Melissa Campanelli, Adriano Salaroli, Antonietta Ferretti, Maria D Caputo, Luigi Petrucci, Robin Foà, Gioia Colafigli, Anna Guarini, Francesca Romana Mauro
About 75% of patients with chronic lymphocytic leukemia (CLL) are more than 65 years at the time of diagnosis. Treatment of the elderly remains complicated due to multiple factors, such as comorbidities, decline in functional reserve and fitness. Sin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fa29e0c9bb52ad4976bf76cf2676f04
http://hdl.handle.net/11573/1466290
http://hdl.handle.net/11573/1466290
Autor:
Francesco Dragoni, Arturo Cafolla, Melissa Campanelli, Laura Potasso, Roberto Foa, Erminia Baldacci, Raffaele Bochicchio
Publikováno v:
European Journal of Haematology. 89:81-86
Oral anticoagulation therapy (OAT), which aims to prevent thromboembolism in patients with atrial fibrillation (AF), is underused in subjects who are over the age of 80 yr because of the associated bleeding risk. The aim of this study was to evaluate
Autor:
Enza Rossi, Alessandro Porcu, Erminia Baldacci, Luigia Manisco, Melissa Campanelli, Arturo Cafolla, Francesco Dragoni, Roberto Foa, Maria Concetta Cursano
Publikováno v:
Drugsaging. 32(3)
The use of oral anticoagulant therapy (OAT) has constantly increased in the prevention of thromboembolism, particularly in patients 80 years of age or older. The aim of this multicentre study was to evaluate the efficacy and safety of vitamin K antag
Autor:
Davide Rossi, Francesca Romana Mauro, Mara Riminucci, Alberto Biggi, Emanuele Nicolai, Fortunato Morabito, Luca Laurenti, Francesca Paoloni, Stephane Chauvie, Robert Foa, Angela Rago, Francesco Autore, Giuseppe Cimino, Andrea Gallamini, Massimo Gentile, Melissa Campanelli, Marta Coscia, Gianluca Gaidano, Gian Mauro Sacchetti, Anna Guarini, Marilena Bellò, Fabio Trastulli
In order to evaluate the predictive value of positron emission tomography-computed tomography (PET/CT) in discriminating the presence of a Richter's syndrome (RS) or a second malignancy (SM), as well as to evaluate its prognostic value in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eff90b9a7bb1a5316963e5ecb6b11956
http://hdl.handle.net/11573/782767
http://hdl.handle.net/11573/782767
Autor:
Sabrina Bossio, Robin Foà, Diana Giannarelli, Melissa Campanelli, Lucio Morabito, Fortunato Morabito, Massimo Gentile, Ernesto Vigna, Anna Grazia Recchia, Iolanda Vincelli, Laura De Stefano, Gianluca Gaidano, Francesca Romana Mauro, Davide Rossi, Giovanni Tripepi
Summary We performed an external and multicentric validation of the nomogram and prognostic index (PI) proposed by the MD Anderson Cancer Center to prognostically stratify chronic lymphocytic leukaemia (CLL) patients in 1502 CLL cases. All six parame
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48d0f203c09318814914cca9248a8277
http://hdl.handle.net/11573/782214
http://hdl.handle.net/11573/782214
Autor:
Melissa Campanelli, Maria Lucia De Luca, Giuliana Alimena, Federico Vozella, Ida Carmosino, Laura Cesini, Roberto Latagliata, Massimo Breccia, Fulvio Massaro, Marco Mancini, Daniela Diverio, Gioia Colafigli, Matteo Molica
Publikováno v:
Blood. 128:1903-1903
Background Early occurrence of severe (≤ 10 g/dl) anemia has been reported in about 5% of newly diagnosed patients with Chronic Myeloid Leukemia (CML) treated with imatinib and is generally transient: in patients responsive to imatinib, however, se